Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Scitara Corp. raises $15m in Series B Financing to disrupt the laboratory data integration market

    Jan 12, 2022, 11:34 AM by
    Scitara Corp, a proven innovator in laboratory digital transformation, today announces the closing of its Series B round with an additional investment of $15m.
    Full story
  • Seqster, National Pancreas Foundation, Launch Pancreatic Disease Patient Registry

    Jan 11, 2022, 17:15 PM by User Not Found
    Bio-IT World | Seqster announced today a multi-year partnership with The National Pancreas Foundation, a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, to create the country’s largest, most inclusive pancreatic disease patient registry. The registry uses Seqster technology to connect to any EHR, genomic DNA test, and wearable/remote monitoring device, providing patients with a complete longitudinal health record in real-time.
    Full story
  • Illumina Teases New Chemistry, Long Reads, Oncology, Proteomics Partnerships

    Jan 11, 2022, 01:00 AM by User Not Found
    Bio-IT World | At the JP Morgan Healthcare Conference—being held virtually again this year—Illumina CEO Francis deSouza outlined Illumina’s record for 2021, announced several new partnerships, and teased new chemistry and new long read technologies.
    Full story
  • Trendspotting: What’s Coming for Bio-IT in 2022

    Jan 10, 2022, 01:00 AM by User Not Found
    Bio-IT World | We spoke with several players in the Bio-IT World vendor community to gain insights and predictions for the coming year. They predicted newer ‘omics, green chemistry, SaaS medical devices, federated learning, XNAT, protein sequencing, and more.
    Full story
  • Antibiotic Research UK calls for change in behaviour to reduce antibiotic prescribing, launches new campaign: What’s bugging you this winter?

    Jan 6, 2022, 16:59 PM by
    Antibiotic prescription rates rise every winter, but new data from the charity Antibiotic Research UK (ANTRUK) and Costello Medical shows how the annual rise in winter prescribing can be reduced. To sustain this reduction in prescribing, ANTRUK is launching its ‘What’s Bugging You This Winter?’ campaign, calling on everyone to understand the role that they can play in tackling antibiotic resistance.
    Full story
  • Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities

    Jan 6, 2022, 16:58 PM by
    Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities Dokumeds brings complementary specialties and multinational footprint in Europe and beyond Research Triangle Park, NC – December 8, 2021 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced that it has acquired Dokumeds, a privately-held European CRO. Established in 1995 and headquartered in Riga, Latvia, Dokumeds has 10 offices and is active across multiple continents. Terms were not disclosed.
    Full story
  • BOC Sciences Provides PseudoUridines for Vaccine R&D

    Jan 6, 2022, 16:58 PM by
    Full story
  • Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances

    Jan 6, 2022, 16:58 PM by
    • Optibrium, IFF and Intellegens’ joint peer-reviewed research published in Journal of Computer Aided Molecular Design • Study demonstrates accuracy and predictive capability of proprietary deep learning method for developing flavours and fragrances, and in drug discovery
    Full story
  • IDDI celebrates its 30th anniversary this year

    Jan 6, 2022, 16:58 PM by
    IDDI celebrates its 30th anniversary
    Full story
  • ATMPS and Assurea LLC launch strategic collaboration for advanced therapy supply chain

    Jan 6, 2022, 16:58 PM by
    Hataali-based deal will empower biotechs with blockchain-based immutable data for a permanent state of inspection readiness
    Full story
  • Curebase Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

    Jan 6, 2022, 16:56 PM by
    Curebase recognized for achievements in Clinical Trials Tech
    Full story
  • Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT

    Jan 6, 2022, 16:56 PM by
    Full story
  • Positive Technologies Upgrades Network Attack Discovery Solution To Identify 33 New Types of Suspicious Network Activities

    Jan 6, 2022, 16:56 PM by
    Positive Technologies today released a new version of its Network Attack Discovery solution, PT NAD, which detects attacks on the perimeter and inside corporate networks, identifies suspicious activity even in encrypted traffic, and helps organizations investigate incidents.
    Full story
  • Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

    Jan 6, 2022, 16:56 PM by
    Full story
  • Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea

    Jan 6, 2022, 16:56 PM by
    Full story
  • HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China

    Jan 6, 2022, 16:56 PM by
    King of Prussia, PA, December 13, 2021: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has collaborated with CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to provide Risk-Based Quality Management (RBQM) expertise and technology in the Chinese region. This market-leading partnership will increase clinical trial efficiency and reduce deviation and bias to obtain accurate patient outcomes.
    Full story
  • STEM Healthcare appoints Dermot Kenny as new CEO

    Jan 6, 2022, 16:56 PM by
    Full story
  • IDDI Becomes a Medidata Rave EDC Partner

    Jan 6, 2022, 16:56 PM by
    IDDI Becomes a Medidata Rave EDC Partner
    Full story
  • Scitara Corp. launches new breakthrough industry Scientific Integration Platform™ to support laboratory digital transformation

    Jan 6, 2022, 16:56 PM by
    Scitara Corporation has launched its new Scientific Integration Platform™ (SIP™) that presents a solution to the lab connectivity challenge and allows true data mobility.
    Full story
  • Qlucore announces major new release for bioinformatics

    Jan 6, 2022, 16:56 PM by
    Full story
  • «
  • 151
  • 152
  • 153 (current)
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy